BlackRock’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-109,531
| Closed | -$8.89K | – | 5710 |
|
2022
Q4 | $8.89K | Sell |
109,531
-2,220
| -2% | -$180 | ﹤0.01% | 5392 |
|
2022
Q3 | $14K | Sell |
111,751
-3,444
| -3% | -$431 | ﹤0.01% | 5474 |
|
2022
Q2 | $32K | Buy |
115,195
+56,664
| +97% | +$15.7K | ﹤0.01% | 5401 |
|
2022
Q1 | $18K | Sell |
58,531
-2,745
| -4% | -$844 | ﹤0.01% | 5492 |
|
2021
Q4 | $140K | Buy |
61,276
+42,030
| +218% | +$96K | ﹤0.01% | 5110 |
|
2021
Q3 | $44K | Buy |
19,246
+239
| +1% | +$546 | ﹤0.01% | 5230 |
|
2021
Q2 | $104K | Buy |
19,007
+18,266
| +2,465% | +$99.9K | ﹤0.01% | 4967 |
|
2021
Q1 | $4K | Hold |
741
| – | – | ﹤0.01% | 5100 |
|
2020
Q4 | $3K | Hold |
741
| – | – | ﹤0.01% | 4895 |
|
2020
Q3 | $1K | Hold |
741
| – | – | ﹤0.01% | 4925 |
|
2020
Q2 | $2K | Hold |
741
| – | – | ﹤0.01% | 4842 |
|
2020
Q1 | $1K | Hold |
741
| – | – | ﹤0.01% | 4864 |
|
2019
Q4 | $0 | Hold |
741
| – | – | ﹤0.01% | 5026 |
|
2019
Q3 | $1K | Sell |
741
-3,654
| -83% | -$4.93K | ﹤0.01% | 4904 |
|
2019
Q2 | $6K | Sell |
4,395
-9,234
| -68% | -$12.6K | ﹤0.01% | 4758 |
|
2019
Q1 | $23K | Sell |
13,629
-896
| -6% | -$1.51K | ﹤0.01% | 4528 |
|
2018
Q4 | $15K | Sell |
14,525
-256
| -2% | -$264 | ﹤0.01% | 4572 |
|
2018
Q3 | $30K | Buy |
14,781
+576
| +4% | +$1.17K | ﹤0.01% | 4540 |
|
2018
Q2 | $35K | Buy |
14,205
+2,548
| +22% | +$6.28K | ﹤0.01% | 4548 |
|
2018
Q1 | $35K | Sell |
11,657
-3,075
| -21% | -$9.23K | ﹤0.01% | 4443 |
|
2017
Q4 | $59K | Buy |
14,732
+440
| +3% | +$1.76K | ﹤0.01% | 4356 |
|
2017
Q3 | $50K | Sell |
14,292
-605
| -4% | -$2.12K | ﹤0.01% | 4410 |
|
2017
Q2 | $43K | Buy |
14,897
+11,356
| +321% | +$32.8K | ﹤0.01% | 4478 |
|
2017
Q1 | $5K | Buy |
+3,541
| New | +$5K | ﹤0.01% | 4733 |
|